Evaluation of an in vitro coronary stent thrombosis model for preclinical assessment

Dylan Perry-Nguyen, Richard G. Jung, Alisha Labinaz, Anne-Claire Duchez, Omar Dewidar, Trevor Simard, Denuja Karunakaran, Kamran Majeed, Kiran Sarathy, Ruonan Li, F. Daniel Ramirez, Pietro Di Santo, Rebecca Rochman, Derek So, Nicolas Foin, Benjamin Hibbert

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)


Stent thrombosis remains an infrequent but significant complication following percutaneous coronary intervention. Preclinical models to rapidly screen and validate therapeutic compounds for efficacy are lacking. Herein, we describe a reproducible, high throughput and cost-effective method to evaluate candidate therapeutics and devices for either treatment or propensity to develop stent thrombosis in an in vitro bench-top model. Increasing degree of stent malapposition (0.00 mm, 0.10 mm, 0.25 mm and 0.50 mm) was associated with increasing thrombosis and luminal area occlusion (4.1 ± 0.5%, 6.3 ± 0.5%, 19.7 ± 4.5%, and 92.6 ± 7.4%, p < 0.0001, respectively). Differences in stent design in the form of bare-metal, drug-eluting, and bioresorbable vascular scaffolds demonstrated differences in stent thrombus burden (14.7 ± 3.8% vs. 20.5 ± 3.1% vs. 86.8 ± 5.3%, p < 0.01, respectively). Finally, thrombus burden was significantly reduced when healthy blood samples were incubated with Heparin, ASA/Ticagrelor (DAPT), and Heparin+DAPT compared to control (DMSO) at 4.1 ± 0.6%, 6.9 ± 1.7%, 4.5 ± 1.2%, and 12.1 ± 1.8%, respectively (p < 0.01). The reported model produces high throughput reproducible thrombosis results across a spectrum of antithrombotic agents, stent design, and degrees of apposition. Importantly, performance recapitulates clinical observations of antiplatelet/antithrombotic regimens as well as device and deployment characteristics. Accordingly, this model may serve as a screening tool for candidate therapies in preclinical evaluation.

Original languageEnglish
Pages (from-to)167-173
Number of pages8
Issue number2
Publication statusPublished - Apr 2019
Externally publishedYes


  • Antiplatelet agents
  • methods
  • optical coherence tomography
  • percutaneous coronary intervention
  • stent thrombosis

Cite this